Jamilet Miranda

630 total citations
18 papers, 461 citations indexed

About

Jamilet Miranda is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Jamilet Miranda has authored 18 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Oncology. Recurrent topics in Jamilet Miranda's work include Molecular Biology Techniques and Applications (3 papers), Bioinformatics and Genomic Networks (3 papers) and Gene expression and cancer classification (3 papers). Jamilet Miranda is often cited by papers focused on Molecular Biology Techniques and Applications (3 papers), Bioinformatics and Genomic Networks (3 papers) and Gene expression and cancer classification (3 papers). Jamilet Miranda collaborates with scholars based in Cuba, Sweden and United Kingdom. Jamilet Miranda's co-authors include Ricardo Bringas, Jorge Fernández-de-Cossío, Alexander J. Martin, María Elena Ochagavia, Marion Bennie, Gerardo Guillén, Rob McConnell, David M. Simpson, Ricardo Cuadra and Anne‐Céline Martin and has published in prestigious journals such as BMC Bioinformatics, BMC Cancer and Archives of Toxicology.

In The Last Decade

Jamilet Miranda

15 papers receiving 447 citations

Peers

Countries citing papers authored by Jamilet Miranda

Since Specialization

Citations

This map shows the geographic impact of Jamilet Miranda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jamilet Miranda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jamilet Miranda more than expected).

Fields of papers citing papers by Jamilet Miranda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jamilet Miranda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jamilet Miranda. The network helps show where Jamilet Miranda may publish in the future.

Co-authorship network of co-authors of Jamilet Miranda

This figure shows the co-authorship network connecting the top 25 collaborators of Jamilet Miranda. A scholar is included among the top collaborators of Jamilet Miranda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jamilet Miranda. Jamilet Miranda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG 2023 ·BMC Cancer ·Jamilet Miranda, (unknown), Ricardo Bringas, Jorge Fernández-de-Cossío, (unknown), (unknown), Iraldo Bello Rivero	0
2	Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach 2021 ·Molecular Medicine ·Jamilet Miranda, Ricardo Bringas, Jorge Fernández-de-Cossío, Yasser Perera	10
3	Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy 2020 ·Journal of Translational Medicine ·Razan Sheta, Magdalena Bachvarova, Marie Plante, Marie‐Claude Renaud, Alexandra Sebastianelli, Jean‐Pierre Grégoire, Jamilet Miranda, Ricardo Bringas, Jean‐Yves Masson, Dimcho Bachvarov	19
4	Gene expression profile in cervical carcinoma cells treated with HeberFERON 2018 ·Bionatura ·(unknown), Julio R. Fernández, Jamilet Miranda, Isabel Guillén, Seidy Pedroso‐Santana, Alexander Martín, María Elena Ochagavia, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
5	Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis 2015 ·Molecular and Cellular Biochemistry ·Yasser Perera, Seidy Pedroso‐Santana, Orlando Borrás‐Hidalgo, (unknown), Jamilet Miranda, (unknown), Viviana Falcón, (unknown), (unknown), Silvio E. Perea	8
6	Differential expression of pro-inflammatory cytokines IL-15Ralpha, IL-15, IL-6 and TNFalpha in synovial fluid from Rheumatoid arthritis patients 2015 ·BMC Musculoskeletal Disorders ·(unknown), (unknown), (unknown), Jamilet Miranda, (unknown), Ricardo Bringas, (unknown), Gerardo Guillén	42
7	Regulation by IFN-α/IFN-γ Co-Formulation (HerberPAG<sup>®</sup>) of Genes Involved in Interferon-STAT-Pathways and Apoptosis in U87MG 2014 ·Current Topics in Medicinal Chemistry ·(unknown), (unknown), Jamilet Miranda, (unknown), (unknown), (unknown), (unknown)	7
8	Analysis of gene expression profile for gender in human blood samples 2014 ·Isabel Guillén, Julio R. Fernández, (unknown), (unknown), Junsong Han, Zhiming Zhang, Xiaona Zhang, Yang Gao, Jamilet Miranda, Ricardo Bringas, (unknown)	4
9	Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries 2013 ·International Journal of Clinical Practice ·(unknown), Björn Wettermark, Jamilet Miranda, Marion Bennie, Anne‐Céline Martin, Rickard E. Malmström	24
10	Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications 2013 ·International Journal of Clinical Practice ·Marion Bennie, Iain Bishop, Brian Godman, Corrado Barbui, Emanuel Raschi, Stephen Campbell, Jamilet Miranda, Lars L. Gustafsson	13
11	PP062—Variable approaches in europe to the availability of generic losartan; implications for the future 2013 ·Clinical Therapeutics ·(unknown), Marion Bennie, Anna Bucsics, U. Hesse, Anne‐Céline Martin, Jamilet Miranda, Steven Simoens, Corinne Zara, Lars L. Gustafsson	2
12	Selection of reference genes for use in quantitative reverse transcription PCR assays when using interferons in U87MG 2012 ·Molecular Biology Reports ·(unknown), Julio R. Fernández, Jamilet Miranda, (unknown), José Antônio Silva, (unknown), (unknown), (unknown), (unknown)	9
13	A METHODOLOGY BASED ON MOLECULAR INTERACTIONS AND PATHWAYS TO FIND CANDIDATE GENES ASSOCIATED TO DISEASES: ITS APPLICATION TO SCHIZOPHRENIA AND ALZHEIMER'S DISEASE 2011 ·Journal of Bioinformatics and Computational Biology ·María Elena Ochagavia, Jamilet Miranda, (unknown), Alexander J. Martin, (unknown), Ricardo Bringas, Jorge Fernández-de-Cossío, (unknown)	6
14	BisoGenet: a new tool for gene network building, visualization and analysis 2010 ·BMC Bioinformatics ·Alexander J. Martin, María Elena Ochagavia, (unknown), Jamilet Miranda, Jorge Fernández-de-Cossío, Ricardo Bringas	271
15	Análisis de datos de microarreglos de ADN. Parte II: Cuantificación y análisis de la expresión génica Jamilet Miranda , Ricardo Bringas 2008 ·Biotecnología aplicada ·Jamilet Miranda, Ricardo Bringas	0
16	Análisis de datos de microarreglos de ADN. Parte I: Antecedentes de la tecnología y diseño experimental 2008 ·Biotecnología aplicada ·Jamilet Miranda, Ricardo Bringas	0
17	Efectos del clorpirifos en la salud de trabajadores bananeros de la Lima, Honduras 2006 ·Catharina Wesseling, Aurora Aragón, Marianela Rojas, Luis Blanco, (unknown), (unknown), (unknown), Clemens Ruepert, Jamilet Miranda	4
18	Organophosphate neuropathy due to methamidophos: biochemical and neurophysiological markers 1999 ·Archives of Toxicology ·Rob McConnell, (unknown), Ricardo Cuadra, (unknown), Matthew Keifer, (unknown), Jamilet Miranda, Hassan A. N. El‐Fawal, Mary S. Wolff, David M. Simpson, Ingrid E. Lundberg	41

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact